Shareholder Class Actions Related to Sanofi-Aventis Acquisition of Chattem

We served as co-counsel to Sanofi-Aventis S.A. in shareholder class actions filed following announcement of its acquisition of Chattem, Inc. for $1.9 billion.

Sanofi S.A. (EURONEXT: SAN; NYSE: SNY). is a global and diversified healthcare leader, that discovers, develops and distributes therapeutic solutions focused on patients’ needs. The company name was Sanofi-Aventis S.A. from 2004 – 2011.

You Also May Be Interested In:

  • Representation of Mallinckrodt Pharmaceuticals, a global pharmaceutical manufacturer, in numerous cases in courts across Tennessee, Kentucky, and Virginia

    Bass, Berry & Sims represents Mallinckrodt Pharmaceuticals, a global pharmaceutical manufacturer, in numerous cases in courts across Tennessee, Kentucky, and...
    Client Type: Public Company
  • Representation of  J. Alexander’s Holdings, Inc. (NYSE: JAX), owner and operator of J. Alexander’s Restaurant, Redlands Grill, Stoney River Steakhouse and Grill and selected other restaurants, in its $220 million all cash sale to SPB Hospitality LLC, a leading operator and franchisor of full-service dining restaurants.

    Since J. Alexander’s first opened in 1991, Bass, Berry & Sims has served as primary corporate and securities counsel to the company for more than 30 years.  Additional details about the transaction can be found in the official news release.

    We represented J. Alexander’s Holdings, Inc. (NYSE: JAX), owner and operator of J. Alexander’s Restaurant, Redlands Grill, Stoney River Steakhouse...
  • We represented Helix Sleep, Inc. (Helix) in its sale to Cerberus Capital Management, L.P. (Cerberus), a global leader in alternative investing.

    We represented Helix Sleep, Inc. (Helix), a custom home furnishings and mattress company, in its sale to Cerberus Capital Management,...